You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

CLINICAL TRIALS PROFILE FOR DURAMORPH PF


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Duramorph Pf

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00335517 ↗ Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients Completed EKR Therapeutics, Inc N/A 2006-06-01 The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.
NCT00335517 ↗ Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients Completed University of Rochester N/A 2006-06-01 The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.
NCT00385541 ↗ Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA) Completed Columbia University Phase 4 2003-11-01 Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at the institution that hydromorphone causes less side effects but this has not been studied. The study proposes to treat the patients with either morphine or hydromorphone and determine how much nausea, vomiting, and itching they have with each drug
NCT01298778 ↗ High Pain Intervention in Cesarean Sections Completed Wake Forest School of Medicine N/A 2010-08-01 In previous studies the investigators have seen that the severity of pain one day after cesarean delivery can predict the presence of pain and depression 2 months later. The investigators believe those at risk for severe acute post-partum pain can be identified, and medical interventions can be tailored to manage postoperative pain more effectively.
NCT01298778 ↗ High Pain Intervention in Cesarean Sections Completed Wake Forest University Health Sciences N/A 2010-08-01 In previous studies the investigators have seen that the severity of pain one day after cesarean delivery can predict the presence of pain and depression 2 months later. The investigators believe those at risk for severe acute post-partum pain can be identified, and medical interventions can be tailored to manage postoperative pain more effectively.
NCT01362998 ↗ Epidural Morphine Versus Epidural Fentanyl Infusion Following Cesarean Section Unknown status Goodman, Evan, M.D. N/A 2011-03-01 For post-Cesarean analgesia, the investigators will compare the efficacy of single-shot epidural preservative free morphine with a continuous epidural fentanyl infusion. The investigators will be comparing the patient's pain level and satisfaction with the two techniques, as well as the side effects that the patients experience, such as itching, nausea, back pain and respiratory depression.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Duramorph Pf

Condition Name

Condition Name for Duramorph Pf
Intervention Trials
Pain 9
Cesarean Section 4
Pain, Postoperative 3
Analgesia, Obstetrical 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Duramorph Pf
Intervention Trials
Pain, Postoperative 10
Post-Dural Puncture Headache 2
Headache 2
Osteoarthritis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Duramorph Pf

Trials by Country

Trials by Country for Duramorph Pf
Location Trials
United States 63
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Duramorph Pf
Location Trials
New York 11
Ohio 7
Virginia 5
Minnesota 4
North Carolina 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Duramorph Pf

Clinical Trial Phase

Clinical Trial Phase for Duramorph Pf
Clinical Trial Phase Trials
Phase 4 20
Phase 3 2
Phase 2 3
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Duramorph Pf
Clinical Trial Phase Trials
Completed 17
Terminated 7
Unknown status 4
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Duramorph Pf

Sponsor Name

Sponsor Name for Duramorph Pf
Sponsor Trials
Pacira Pharmaceuticals, Inc 3
Virginia Commonwealth University 3
Mayo Clinic 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Duramorph Pf
Sponsor Trials
Other 37
Industry 6
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.